Heron Therapeutics (HRTX) Debt Ratio: 2016-2025
Historic Debt Ratio for Heron Therapeutics (HRTX) over the last 2 years, with Sep 2025 value amounting to 0.43.
- Heron Therapeutics' Debt Ratio rose 283.93% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 283.93%. This contributed to the annual value of 0.11 for FY2024, which is 1.56% down from last year.
- As of Q3 2025, Heron Therapeutics' Debt Ratio stood at 0.43, which was up 303.71% from 0.11 recorded in Q1 2025.
- In the past 5 years, Heron Therapeutics' Debt Ratio ranged from a high of 0.43 in Q3 2025 and a low of 0.10 during Q3 2023.
- Moreover, its 3-year median value for Debt Ratio was 0.11 (2023), whereas its average is 0.15.
- Examining YoY changes over the last 5 years, Heron Therapeutics' Debt Ratio showed a top increase of 283.93% in 2025 and a maximum decrease of 4.68% in 2025.
- Quarterly analysis of 3 years shows Heron Therapeutics' Debt Ratio stood at 0.11 in 2023, then dropped by 1.56% to 0.11 in 2024, then spiked by 283.93% to 0.43 in 2025.
- Its Debt Ratio stands at 0.43 for Q3 2025, versus 0.11 for Q1 2025 and 0.11 for Q4 2024.